Vertex Pharmaceuticals (Europe) Ltd is 10% Owner at CRISPR Therapeutics AG (CRSP). They have made 1 open-market trade across 1 company since 2018, most recently 2018-12-24.
CIK 0001761216
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $4.4M since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CRSP | 5,275,345 | $260.0M |
Shares reported on the most recent Form 4, priced at the 2018-12-26 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRSP | BUY | 2018-12-21 | 2018-12-26 | $24.08 | $4.4M | +30.1% | +27.0% | +33.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.